Having established that BEV treatment induces activated glycolysis in GBM characterized by increased LDHA expression and lactate production 10,39; we next investigated whether the addition of 3PO to BEV monotherapy enables the restrain of LDHA and lactate levels in GBM. This evidence concerns the gene LDHA and glioblastoma.